Outlook Therapeutics, Inc. (OTLK)
0.4294
+0.04
(+10.10%)
USD |
NASDAQ |
Feb 06, 16:00
0.4281
0.00 (0.00%)
After-Hours: 20:00
Outlook Therapeutics SG&A Expense (TTM) : 39.97M for June 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 96.29M |
| Amicus Therapeutics, Inc. | 353.07M |
| Neogen Corp. | 413.61M |
| CorMedix, Inc. | 75.56M |
| ACADIA Pharmaceuticals, Inc. | 523.36M |